{"id":1597,"date":"2014-08-27T11:16:29","date_gmt":"2014-08-27T09:16:29","guid":{"rendered":"http:\/\/news.embl.de\/?p=1597"},"modified":"2025-04-23T15:52:28","modified_gmt":"2025-04-23T13:52:28","slug":"nordic-networks","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/","title":{"rendered":"Nordic networks"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\">What are the key objectives?<\/h3>\n\n\n\n<p>The central goal is translational medicine \u2013 taking discoveries from the lab to the clinic to health benefits. There have already been significant improvements in healthcare as a result of translational research, but there is also huge potential to push forward and to do this better. Flagship projects increasingly incorporate large data sets from genomics, proteomics, biobanks, health registries, as well as information on communities. Since the partnership agreement was signed we have become a powerful force and have created excellent infrastructures, networks and training programmes geared towards tackling these research challenges. Collectively, we are focussed on enhancing the research enterprise so that patients can benefit quicker from advances, while at the same time facilitating highly ambitious blue-skies research that is crucial in making translational medicine happen.<\/p>\n\n\n\n<blockquote class=\"vf-blockquote\"><p>Since the partnership agreement was signed we have become a powerful force and have created excellent infrastructures, networks and training programmes<\/p><\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\">Can you give some examples of creative flows in the partnership?<\/h3>\n\n\n\n<p>The partnership spans almost the entire research spectrum: human genomics and systems medicine (FIMM); infection and microbiome (MIMS); brain circuitry and neuronal disease (DANDRITE); and disease mechanisms (NCMM) \u2013 there are almost too many examples to choose from! One exciting area is the increasing use of tools, algorithms and other platforms to integrate genetic and molecular information with traditional clinical knowledge and tailor treatment to individual patients. Another is the development of elegant structural biology methods to better understand tricky elements such as membrane proteins and molecular transport. A third is the range of different microscopy technologies at different centres, which has led to some exciting joint research projects and dedicated training programmes. But there are many more. Our connections with EMBL are very important in this respect \u2013 we have adopted the EMBL model in terms of international recruitment and scientific reviews, which really increases quality at all levels, and we initiate valuable scientific exchanges, joint appointments, and symposia like the one here at Ume\u00e5.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">How about the main challenges?<\/h3>\n\n\n\n<p>The partnership is spread across four different countries, which can create logistical challenges, as well as being quite young. But there have been ways to turn this to our advantage, especially with the <a title=\"Denmark joins the Nordic Partnership\" href=\"http:\/\/www.embl.de\/aboutus\/communication_outreach\/media_relations\/2013\/130305_Heidelberg-Aarhus\/index.html\" target=\"_blank\" rel=\"noopener noreferrer\">addition of DANDRITE as the partnership\u2019s fourth node in 2013 and the extension of the partnership agreement for another 10 years<\/a>. We are focused on enhancing the cohesion that we have established thus far and further increasing our interactions with EMBL to improve our knowledge exchange and use of available infrastructures&nbsp;\u2013 as we grow we will see this happening more and more. Other priorities include enhancing connections with local research communities, as well as gaining more recognition beyond the world of science.<\/p>\n\n\n\n<blockquote class=\"vf-blockquote\"><p>We are focused on enhancing the cohesion that we have established thus far and further increasing our interactions with EMBL<\/p><\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\">What is your own group focussed on?<\/h3>\n\n\n\n<p>Our group is interested in how signalling and signalling cues to the immune system regulate immune responses, specifically in diseases such as cancer and viral infections. Flow cytometry-based technologies are allowing us to understand signal networks and learn more about specific drug responses in individual patients, work that is carried out in collaboration with researchers at FIMM.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">What do you do in your spare time if you have any?<\/h3>\n\n\n\n<p>I like cross-country skiing, hiking, reading, as well as trying my hand at some DIY.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nordic partners focus on &#8220;enhancing research enterprise&#8221;, says Kjetil Task\u00e9n<\/p>\n","protected":false},"author":10,"featured_media":1598,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[19489,5758,19497,5786,24,19495,19493,110,9978,25,912],"embl_taxonomy":[],"class_list":["post-1597","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lab-matters","tag-dandrite","tag-denmark","tag-fimm","tag-finland","tag-governance","tag-mims","tag-ncmbm","tag-nordic-embl-partnership","tag-norway","tag-partnerships","tag-sweden"],"acf":{"article_intro":"<p>Researchers are convening in Ume\u00e5, Sweden this week for the annual network meeting of the <a title=\"Nordic EMBL Partnership for Molecular Medicine\" href=\"http:\/\/www.embl.de\/research\/partnerships\/remote\/nordic\/index.html\" target=\"_blank\">Nordic EMBL Partnership for Molecular Medicine<\/a>. The Partnership \u2013 which has grown from scratch in 2008 to more than 40 research groups mostly led by young researchers \u2013 brings together the Danish Institute for Translational Neuroscience (DANDRITE), the Institute for Molecular Medicine Finland (FIMM), the Laboratory for Molecular Infection Medicine Sweden (MIMS), the Centre for Molecular Medicine Norway (NCMM) and EMBL with the shared goal of tailoring approaches to the benefit of patients. Ahead of the meeting, we caught up with NCMM Director and speaker of the Partnership Kjetil Task\u00e9n.<\/p>\n","related_links":[{"link_description":"","link_url":""},{"link_description":"","link_url":""},{"link_description":"","link_url":""},{"link_description":"","link_url":""},{"link_description":"","link_url":""},{"link_description":"","link_url":""},{"link_description":"","link_url":""}],"article_sources":false,"vf_locked":false,"featured":false,"color":"#007B53","show_featured_image":false,"field_target_display":"embl","source_article":false,"in_this_article":false,"press_contact":"None"},"embl_taxonomy_terms":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nordic networks | EMBL<\/title>\n<meta name=\"description\" content=\"How are our Nordic partners &quot;enhancing research enterprise&quot; by tapping into EMBL resources?\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nordic networks | EMBL\" \/>\n<meta property=\"og:description\" content=\"How are our Nordic partners &quot;enhancing research enterprise&quot; by tapping into EMBL resources?\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-08-27T09:16:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-23T13:52:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"465\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Adam Gristwood\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Adam Gristwood\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/\"},\"author\":{\"name\":\"Adam Gristwood\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/f7c8259826dbd1b46613f2b3c6d88953\"},\"headline\":\"Nordic networks\",\"datePublished\":\"2014-08-27T09:16:29+00:00\",\"dateModified\":\"2025-04-23T13:52:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/\"},\"wordCount\":560,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg\",\"keywords\":[\"dandrite\",\"denmark\",\"fimm\",\"finland\",\"governance\",\"mims\",\"ncmbm\",\"nordic embl partnership\",\"norway\",\"partnerships\",\"sweden\"],\"articleSection\":[\"Lab Matters\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/\",\"url\":\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/\",\"name\":\"Nordic networks | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg\",\"datePublished\":\"2014-08-27T09:16:29+00:00\",\"dateModified\":\"2025-04-23T13:52:28+00:00\",\"description\":\"How are our Nordic partners \\\"enhancing research enterprise\\\" by tapping into EMBL resources?\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg\",\"width\":620,\"height\":465,\"caption\":\"NCMM Director and speaker of the Nordic EMBL Partnership for Molecular Medicine, Kjetil Task\u00e9n. PHOTO: EMBL Photolab\/Marietta Schupp\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/f7c8259826dbd1b46613f2b3c6d88953\",\"name\":\"Adam Gristwood\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/91daf7f996316d4d6241cf3257fa6250043a1f95e909c92174d292c8f1d13b3a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/91daf7f996316d4d6241cf3257fa6250043a1f95e909c92174d292c8f1d13b3a?s=96&d=mm&r=g\",\"caption\":\"Adam Gristwood\"},\"description\":\"Adam Gristwood is a journalist and EMBL alumnus. Mainly reporting on life sciences, he\u2019s covered stories from the Atacama Desert, the Large Hadron Collider, and a helicopter.\",\"url\":\"https:\/\/www.embl.org\/news\/author\/adam-gristwood\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nordic networks | EMBL","description":"How are our Nordic partners \"enhancing research enterprise\" by tapping into EMBL resources?","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/","og_locale":"en_US","og_type":"article","og_title":"Nordic networks | EMBL","og_description":"How are our Nordic partners \"enhancing research enterprise\" by tapping into EMBL resources?","og_url":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2014-08-27T09:16:29+00:00","article_modified_time":"2025-04-23T13:52:28+00:00","og_image":[{"width":620,"height":465,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg","type":"image\/jpeg"}],"author":"Adam Gristwood","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Adam Gristwood","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/"},"author":{"name":"Adam Gristwood","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/f7c8259826dbd1b46613f2b3c6d88953"},"headline":"Nordic networks","datePublished":"2014-08-27T09:16:29+00:00","dateModified":"2025-04-23T13:52:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/"},"wordCount":560,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg","keywords":["dandrite","denmark","fimm","finland","governance","mims","ncmbm","nordic embl partnership","norway","partnerships","sweden"],"articleSection":["Lab Matters"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/","url":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/","name":"Nordic networks | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg","datePublished":"2014-08-27T09:16:29+00:00","dateModified":"2025-04-23T13:52:28+00:00","description":"How are our Nordic partners \"enhancing research enterprise\" by tapping into EMBL resources?","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/lab-matters\/nordic-networks\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg","width":620,"height":465,"caption":"NCMM Director and speaker of the Nordic EMBL Partnership for Molecular Medicine, Kjetil Task\u00e9n. PHOTO: EMBL Photolab\/Marietta Schupp"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/f7c8259826dbd1b46613f2b3c6d88953","name":"Adam Gristwood","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/91daf7f996316d4d6241cf3257fa6250043a1f95e909c92174d292c8f1d13b3a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/91daf7f996316d4d6241cf3257fa6250043a1f95e909c92174d292c8f1d13b3a?s=96&d=mm&r=g","caption":"Adam Gristwood"},"description":"Adam Gristwood is a journalist and EMBL alumnus. Mainly reporting on life sciences, he\u2019s covered stories from the Atacama Desert, the Large Hadron Collider, and a helicopter.","url":"https:\/\/www.embl.org\/news\/author\/adam-gristwood\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2014\/08\/1408_Kjetil1.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/1597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=1597"}],"version-history":[{"count":10,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/1597\/revisions"}],"predecessor-version":[{"id":19703,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/1597\/revisions\/19703"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/1598"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=1597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=1597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=1597"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=1597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}